Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 08, 2016 10:07 AM ET


Company Overview of Morria Biopharmaceuticals Inc.

Executive Profile

Mark S. Cohen

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Mr. Mark Cohen serves as the President of Morria Biopharmaceuticals Inc. Mr. Cohen is a Senior Partner and Chair of the Life Science Group at Pearl Cohen Zedek Latzer, LLP. He served as the Principal Executive Officer of Celsus Therapeutics Plc. Mr. Cohen served as Chairman for Celsus Therapeutics Plc since December 21, 2004. He serves as Vice Chairman of Akari Therapeutics, Plc. He is admitted to the New York and New Jersey bars in the United States and the Israel Bar, ...

Corporate Headquarters

10 Rockefeller Center
New York, New York 10020

United States

Phone: 917-361-5210
Fax: 425-952-1967

Board Members Memberships

Vice Chairman


New York University
Rutgers, The State University of New Jersey
University Of Baltimore School Of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Morria Biopharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at